SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

FEINBERG LARRY N

(Last)

(First)

(Middle)

200 GREENWICH AVENUE

(Street)

GREENWICH

06830

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
HANSEN MEDICAL INC [ HNSN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2014

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.0001 per share								226,598	D
Common Stock, par value $0.0001 per share								13,657,006	I	See footnotes⁽²⁰⁾⁽¹⁾
Common Stock, par value $0.0001 per share								3,436,713	I	See footnotes⁽²⁰⁾⁽²⁾
Common Stock, par value $0.0001 per share								1,914,222	I	See footnotes⁽²⁰⁾⁽³⁾
Common Stock, par value $0.0001 per share								39,500	I	See footnotes⁽²⁰⁾⁽⁴⁾
Common Stock, par value $0.0001 per share								190,500	I	See footnotes⁽²⁰⁾⁽⁵⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series B Warrant	$1.5	08/11/2014		J⁽⁶⁾			2,382,426	08/08/2013	08/08/2015	Common Stock	2,382,426	⁽⁶⁾	0	I	See footnotes⁽²⁰⁾⁽⁶⁾⁽⁷⁾
Series B Warrant	$1.5	08/11/2014		J⁽⁶⁾			585,933	08/08/2013	08/08/2015	Common Stock	585,933	⁽⁶⁾	0	I	See footnotes⁽²⁰⁾⁽⁶⁾⁽⁸⁾
Series B Warrant	$1.5	08/11/2014		J⁽⁶⁾			326,362	08/08/2013	08/08/2015	Common Stock	326,362	⁽⁶⁾	0	I	See footnotes⁽²⁰⁾⁽⁶⁾⁽⁹⁾
Series C Warrant	$2	08/11/2014		J⁽⁶⁾			2,382,426	08/08/2013	08/08/2015	Common Stock	2,382,426	⁽⁶⁾	0	I	See footnotes⁽²⁰⁾⁽⁶⁾⁽¹⁰⁾
Series C Warrant	$2	08/11/2014		J⁽⁶⁾			585,933	08/08/2013	08/08/2015	Common Stock	585,933	⁽⁶⁾	0	I	See footnotes⁽¹¹⁾⁽²⁰⁾⁽⁶⁾
Series C Warrant	$2	08/11/2014		J⁽⁶⁾			326,362	08/08/2013	08/08/2015	Common Stock	326,362	⁽⁶⁾	0	I	See footnotes⁽¹²⁾⁽²⁰⁾⁽⁶⁾
Series B/C Exchange Warrant	$1.13	08/11/2014		J⁽⁶⁾		4,656,852		08/11/2014	08/25/2014	Common Stock	4,656,852	⁽⁶⁾	4,656,852	I	See footnotes⁽¹³⁾⁽¹⁴⁾⁽²⁰⁾
Series B/C Exchange Warrant	$1.13	08/11/2014		J⁽⁶⁾		1,171,866		08/11/2014	08/25/2014	Common Stock	1,171,866	⁽⁶⁾	1,171,866	I	See footnotes⁽¹³⁾⁽¹⁵⁾⁽²⁰⁾
Series B/C Exchange Warrant	$1.13	08/11/2014		J⁽⁶⁾		652,724		08/11/2014	08/25/2014	Common Stock	652,724	⁽⁶⁾	652,724	I	See footnotes⁽¹³⁾⁽¹⁶⁾⁽²⁰⁾
Series D Warrant	$1.13	08/11/2014		J⁽⁶⁾		1,431,983		02/11/2015	08/11/2019	Common Stock	1,431,983	⁽⁶⁾	1,431,983	I	See footnotes⁽¹³⁾⁽¹⁷⁾⁽²⁰⁾
Series D Warrant	$1.13	08/11/2014		J⁽⁶⁾		360,350		02/11/2015	08/11/2019	Common Stock	360,350	⁽⁶⁾	360,350	I	See footnotes⁽¹³⁾⁽¹⁸⁾⁽²⁰⁾
Series D Warrant	$1.13	08/11/2014		J⁽⁶⁾		200,712		02/11/2015	08/11/2019	Common Stock	200,712	⁽⁶⁾	200,712	I	See footnotes⁽¹³⁾⁽¹⁹⁾⁽²⁰⁾

1. Name and Address of Reporting Person^*

FEINBERG LARRY N

(Last)

(First)

(Middle)

200 GREENWICH AVENUE

(Street)

GREENWICH

06830

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

ORACLE PARTNERS LP

(Last)

(First)

(Middle)

C/O ORACLE INVESTMENT MANAGEMENT, INC.

200 GREENWICH AVENUE

(Street)

GREENWICH

06830

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Oracle Associates LLC

(Last)

(First)

(Middle)

C/O ORACLE INVESTMENT MANAGEMENT, INC.

200 GREENWICH AVENUE

(Street)

GREENWICH

06830

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

Explanation of Responses:

1. See Exhibit 99.1, note 1

2. See Exhibit 99.1, note 2

3. See Exhibit 99.1, note 3

4. See Exhibit 99.1, note 4

5. See Exhibit 99.1, note 5

6. See Exhibit 99.1, note 6

7. See Exhibit 99.1, note 7

8. See Exhibit 99.1, note 8

9. See Exhibit 99.1, note 9

10. See Exhibit 99.1, note 10

11. See Exhibit 99.1, note 11

12. See Exhibit 99.1, note 12

13. See Exhibit 99.1, note 13

14. See Exhibit 99.1, note 14

15. See Exhibit 99.1, note 15

16. See Exhibit 99.1, note 16

17. See Exhibit 99.1, note 17

18. See Exhibit 99.1, note 18

19. See Exhibit 99.1, note 19

20. See Exhibit 99.1, note 20

Remarks:

Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information and Signatures

	/s/ Larry N. Feinberg	08/12/2014
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.